Literature DB >> 27485165

MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS.

Yongqi Long1, Zhiping Wu2, Xinhua Yang1, Lei Chen1, Zhijun Han1, Yulong Zhang1, Jinge Liu1, Wenjin Liu1, Xinyi Liu1.   

Abstract

MicroRNAs (miRs) have important roles in the parthenogenesis of malignancies. While it has been suggested that deregulation of miR‑101 is involved in bladder cancer, the underlying mechanisms have remained largely elusive. The present study aimed to investigate the roles of miR‑101 in the regulation of bladder cancer cell proliferation and invasion. Reverse‑transcription quantitative polymerase chain reaction analysis revealed that the expression of miR‑101 was significantly reduced in the HT‑1376, BIU87, T24 and 5637 several human bladder cancer cell lines compared to that in the SV‑HUC‑1 normal bladder epithelial cell line. Furthermore, a Targetscan search and a luciferase assay were used to identify c‑FOS as a novel target of miR‑101, and western blot analysis indicated that the protein expression of c‑FOS was shown to be negatively regulated by miR‑101 in bladder cancer T24 cells; however, c‑FOS mRNA expression was not affected. In addition, plasmid‑mediated overexpression of miR‑101 and small hairpin RNA‑mediated inhibition of c‑FOS significantly inhibited the proliferation and invasive capacity of T24 cells, as indicated by an MTT and a Transwell assay, respectively. However, plasmid‑mediated overexpression of c‑FOS reversed the inhibitory effects of miR‑101 overexpression on T24‑cell proliferation and invasion. In conclusion, the present study demonstrated that miR‑101 inhibits the proliferation and invasion of bladder cancer cells, at least partly via targeting c‑FOS, suggesting that miR-101/c‑FOS signaling may represent a potential therapeutic target for bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27485165     DOI: 10.3892/mmr.2016.5534

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  13 in total

1.  MicroRNA-192 inhibits the proliferation, migration and invasion of osteosarcoma cells and promotes apoptosis by targeting matrix metalloproteinase-11.

Authors:  Guowei Shang; Yang Mi; Yingwu Mei; Guanghui Wang; Yadong Wang; Xinjie Li; Yisheng Wang; Yuebai Li; Guoqiang Zhao
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

2.  Alpinumisoflavone suppresses tumour growth and metastasis of clear-cell renal cell carcinoma.

Authors:  Tingting Wang; Yuhua Jiang; Lei Chu; Tianhui Wu; Jie You
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

3.  Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.

Authors:  Yuu Saitoh; Tomohiro Umezu; Satoshi Imanishi; Michiyo Asano; Seiichiro Yoshizawa; Seiichiro Katagiri; Tamiko Suguro; Hiroaki Fujimoto; Daigo Akahane; Chiaki Kobayashi-Kawana; Junko H Ohyashiki; Kazuma Ohyashiki
Journal:  Oncol Lett       Date:  2020-01-09       Impact factor: 2.967

4.  1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.

Authors:  Yingyu Ma; Wei Luo; Brittany L Bunch; Rachel N Pratt; Donald L Trump; Candace S Johnson
Journal:  Oncotarget       Date:  2017-07-27

5.  Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity.

Authors:  Abhishek Tyagi; Kanchan Vishnoi; Harsimrut Kaur; Yogesh Srivastava; Bal Gangadhar Roy; Bhudev C Das; Alok C Bharti
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

Review 6.  Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.

Authors:  Cecilia Pop-Bica; Diana Gulei; Roxana Cojocneanu-Petric; Cornelia Braicu; Bogdan Petrut; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

7.  Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Yuka I Kawasawa; Milind Mahajan; Niraj J Gusani; Arun J Sanyal; Dino J Ravnic
Journal:  Sci Rep       Date:  2018-05-22       Impact factor: 4.379

8.  Novel sericin-based hepatocyte serum-free medium and sericin's effect on hepatocyte transcriptome.

Authors:  Yun Huang; Qing Peng; Hai-Yan Li; Zhi-Dong Jia; Yang Li; Yi Gao
Journal:  World J Gastroenterol       Date:  2018-08-14       Impact factor: 5.742

9.  miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro.

Authors:  Theresa Kordaß; Claudia E M Weber; David Eisel; Antonino A Pane; Wolfram Osen; Stefan B Eichmüller
Journal:  Oncotarget       Date:  2018-08-21

10.  MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma.

Authors:  Xiaoyan Chen
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.